Latest Food & Drug Administration news
Was the FDA Too Quick Approving Test for Opioid Addiction Risk?
posted April 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Maker Is Pulling Controversial ALS Drug Relyvrio Off the Market
posted April 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Anti-smoking Groups Sue FDA Again Over Menthol Ban Delays
posted April 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
High-Strength Lidocaine Skin Creams Can Cause Seizures, Heart Trouble, FDA Warns
posted March 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction 
2016 to 2024 Saw Increase in Patients Using Medical Cannabis 
FDA Now Providing Daily Updates on Adverse Events 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
